What is NDC 69539-110?

69539-110 is the product NDC for Oseltamivir phosphate, Oseltamivir phosphate 45 mg/1 capsule, listed with the FDA by MSN LABORATORIES PRIVATE LIMITED.

MSN LABORATORIES PRIVATE LIMITED, NDC labeler code 69539. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oseltamivir phosphate?

105 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oseltamivir phosphate NDC 69539-110 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69539-110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69539-0110Add the package segment from the table below.

Product information

Brand name (proprietary): Oseltamivir phosphate
Generic name (nonproprietary): oseltamivir phosphate
Active ingredients: Oseltamivir phosphate — 45 mg/1
Dosage form: Capsule
Route: Oral
Labeler: MSN LABORATORIES PRIVATE LIMITEDNDC labeler code 69539
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212544
Marketing start: May 22, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Neuraminidase Inhibitors (Mechanism)
Identifiers: Product ID 69539-110_1eceb65e-b7b6-42ff-9fb7-2d47a6e978c3SPL ID 1eceb65e-b7b6-42ff-9fb7-2d47a6e978c3SPL set ID 1b7a02ca-ee0e-4853-91e6-71a79f2bc040RxCUI 312122, 728109, 728113UNII 4A3O49NGEZ
Pharmacologic class: Neuraminidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Nov 20, 2025.

Indications (excerpt from the label)

Oseltamivir phosphate capsules are an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours. (1.1) • Prophylaxis of influenza A and B in patients 1 year and older. (1.2) Limitations of Use: • Not a substitute for annual influenza vaccination. (1.3) • Consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use. (1.3) • Not recommended for patients with end-stage renal disease not undergoing dialysis. (1.3) 1.1 Treatment of Influenza Oseltamivir phosphate capsules are indicated for the tre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69539-110

What is NDC 69539-110?: 69539-110 is the product NDC for Oseltamivir phosphate, Oseltamivir phosphate 45 mg/1 capsule, listed with the FDA by MSN LABORATORIES PRIVATE LIMITED.
What drug is associated with this NDC?: Oseltamivir phosphate.
What is the active ingredient?: Oseltamivir phosphate.
Who is the labeler?: MSN LABORATORIES PRIVATE LIMITED, NDC labeler code 69539. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oseltamivir phosphate?: 105 other product NDCs are listed under this name. See all Oseltamivir phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oseltamivir phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Inc.	62332-769	62332-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Limited	46708-769	46708-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	SuspensionOral	HEC Pharm USA Inc.	72303-0851	72303-0851-01
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4066	68788-4066-01
oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-101	72673-0101-10
oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-102	72673-0102-10
Oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-320	42677-0320-01
Oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-321	42677-0321-01
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-322	42677-0322-01
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8831	68788-8831-01

All 106 Oseltamivir phosphate NDCs

Other NDCs under ANDA 212544

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212544
Product	Strength	Form · route	Labeler	Product NDC
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Proficient Rx LP	82804-180
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8309
Oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Novadoz Pharmaceuticals LLC	72205-042
Oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Novadoz Pharmaceuticals LLC	72205-043
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Novadoz Pharmaceuticals LLC	72205-044